Rice scientists harness vacuum fluctuations to engineer quantum materials
Peer-Reviewed Publication
Updates every hour. Last Updated: 20-Jun-2025 11:10 ET (20-Jun-2025 15:10 GMT/UTC)
Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces the development of novel pan-KRAS inhibitors of new chemotypes through structure-based drug design, scaffold hopping combined with intense molecular modeling, empowered by the generative chemistry methods of Chemistry42, Insilico’s proprietary generative chemistry platform. Developed in the joint efforts of artificial intelligence and human expertise, the candidate compounds demonstrated pan-KRAS inhibition with potency in the upper nanomolar range. The results have been recently published on ACS Medicinal Chemistry Letters.
A research team led by Peter Baum from the University of Konstanz aims to film and visualize previously hidden processes at the atomic level in space and time. The European Research Council awarded Baum an Advanced Grant of 3.1 million euros to develop innovative methods in ultrafast electron microscopy.